These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1656149)

  • 1. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass.
    Jansen NJ; van Oeveren W; van den Broek L; Oudemans-van Straaten HM; Stoutenbeek CP; Joen MC; Roozendaal KJ; Eysman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):515-25. PubMed ID: 1656149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass.
    Jansen NJ; van Oeveren W; van Vliet M; Stoutenbeek CP; Eysman L; Wildevuur CR
    Eur J Cardiothorac Surg; 1991; 5(4):211-7. PubMed ID: 1711873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children.
    Bronicki RA; Backer CL; Baden HP; Mavroudis C; Crawford SE; Green TP
    Ann Thorac Surg; 2000 May; 69(5):1490-5. PubMed ID: 10881828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study.
    Seghaye MC; Duchateau J; Grabitz RG; Wolff T; Marcus C; Engelhardt W; Hörnchen H; Messmer BJ; von Bernuth G
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):882-92. PubMed ID: 8614150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.
    van Oeveren W; Jansen NJ; Bidstrup BP; Royston D; Westaby S; Neuhof H; Wildevuur CR
    Ann Thorac Surg; 1987 Dec; 44(6):640-5. PubMed ID: 2446574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.
    Keshavjee S; Davis RD; Zamora MR; de Perrot M; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):423-8. PubMed ID: 15678055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass.
    Gu YJ; van Oeveren W; Boonstra PW; de Haan J; Wildevuur CR
    Ann Thorac Surg; 1992 May; 53(5):839-43. PubMed ID: 1315132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass.
    Gu YJ; van Oeveren W; Akkerman C; Boonstra PW; Huyzen RJ; Wildevuur CR
    Ann Thorac Surg; 1993 Apr; 55(4):917-22. PubMed ID: 8466349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor.
    Butler J; Parker D; Pillai R; Westaby S; Shale DJ; Rocker GM
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):25-30. PubMed ID: 8419705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
    Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil leukotriene generation increases after cardiopulmonary bypass.
    Gadaleta D; Fahey AL; Verma M; Ko W; Kreiger KH; Isom OW; Davis JM
    J Thorac Cardiovasc Surg; 1994 Oct; 108(4):642-7. PubMed ID: 7934097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass.
    Jansen NJ; van Oeveren W; Gu YJ; van Vliet MH; Eijsman L; Wildevuur CR
    Ann Thorac Surg; 1992 Oct; 54(4):744-7; discussion 747-8. PubMed ID: 1417233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass.
    Checchia PA; Backer CL; Bronicki RA; Baden HP; Crawford SE; Green TP; Mavroudis C
    Crit Care Med; 2003 Jun; 31(6):1742-5. PubMed ID: 12794414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of depletion of leukocytes and platelets on cardiac dysfunction after cardiopulmonary bypass.
    Chiba Y; Morioka K; Muraoka R; Ihaya A; Kimura T; Uesaka T; Tsuda T; Matsuyama K
    Ann Thorac Surg; 1998 Jan; 65(1):107-13; discussion 113-4. PubMed ID: 9456104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
    Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
    Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ulinastatin treatment on the cardiopulmonary bypass-induced hemodynamic instability and pulmonary dysfunction.
    Nakanishi K; Takeda S; Sakamoto A; Kitamura A
    Crit Care Med; 2006 May; 34(5):1351-7. PubMed ID: 16540949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.